T. Rowe Price Investment Management, Inc.
Position in PCVX — Vaxcyte, Inc.
CIK 1897612
BALTIMORE, MD
Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$709,619,068
+$4,976,221 QoQ
Shares Held
12,207,450
+0.7% QoQ
Ownership
8.20%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#3
of 325 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026T. Rowe Price Investment Management, Inc. holds $12,244,164,567 across 51 Biotechnology names. PCVX ranks #5 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
6,754,846 | $1,801,652,525 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,642,173 | $1,698,463,338 | |
| 3 | CYTK |
Cytokinetics Inc
|
18,718,498 | $1,594,628,844 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
6,257,261 | $717,520,118 | |
| 5 | PCVX |
Vaxcyte, Inc.
This page
|
12,207,450 | $709,619,068 | |
| 6 | DYN |
Dyne Therapeutics, Inc.
|
30,912,287 | $686,561,894 | |
| 7 | CGON |
CG Oncology, Inc.
|
6,616,899 | $470,130,673 | |
| 8 | IMNM |
Immunome Inc.
|
19,676,883 | $416,953,150 |
All Filings in PCVX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $709,619,068 | 12,207,450 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $704,642,847 | 12,126,017 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $308,338,670 | 6,682,676 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $299,516,925 | 8,315,295 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $195,096,541 | 6,001,124 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $102,053,612 | 2,702,691 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $234,178,293 | 2,860,717 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $463,230,925 | 4,053,828 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $303,745,695 | 4,022,589 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $242,703,175 | 3,552,967 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $78,251,374 | 1,246,041 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $61,411,935 | 1,204,628 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $57,077,324 | 1,142,918 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $27,506,834 | 733,907 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $24,523,356 | 511,436 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||